This inventor holds 48 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Thermal Transfer Technology. Top assignees: Dai Nippon Printing Co., Ltd., Dai Nippon Insatsu Kabushiki Kaisha, Teijin Pharma Limited. Active years: 1990-2025.
Location History:
- Shinjuku, JP (1990)
- Tokyo-to, JP (1996 - 2000)
- Hino, JP (2010 - 2013)
- Atlanta, GA (US) (2015)
- Saitama, JP (1994 - 2016)
- Tokyo, JP (1991 - 2023)
Company Filing History:
22 out of 3,208 
9 out of 412 
7 out of 126 
Years Active: 1990-2025
Areas of Expertise:
Title: Innovations by Hiroshi H. Eguchi: Pioneering Developments in Humanized Antibodies
Introduction
Hiroshi H. Eguchi, based in Tokyo, Japan, is a distinguished inventor known for his significant contributions to the field of biotechnology. With an impressive portfolio of 43 patents, his work primarily focuses on humanized antibodies, which hold promise for advancements in medical treatments and therapies.
Latest Patents
Among his notable inventions is the anti-IGF-I receptor humanized antibody, designed to increase muscle mass without lowering blood glucose levels. This humanized antibody comprises a specific amino acid sequence, specifically CDR sequences identified as SEQ ID NOs: 1 to 6, that bind to the IGF-I receptor's extracellular domain. Additionally, Eguchi's recent patent pertains to humanized antibodies aimed at treating or preventing cognitive disorders. This invention employs methods and compositions that specifically bind to phosphorylated tau protein at serine position 413, potentially revolutionizing treatment protocols for neurological conditions.
Career Highlights
Hiroshi H. Eguchi has worked with leading companies in the industry, including Dai Nippon Printing Co., Ltd. and Dai Nippon Insatsu Kabushiki Kaisha. His professional journey reflects a commitment to innovation, continuously striving to improve human health through advanced scientific research and application.
Collaborations
Throughout his career, Eguchi has collaborated with notable colleagues such as Masayuki M. Nakamura and Komei Kafuku. These partnerships have contributed to the development of groundbreaking technologies and methodologies, underscoring the importance of teamwork in advancing scientific discovery.
Conclusion
Hiroshi H. Eguchi's dedication to innovation in the field of biotechnology demonstrates the potential of humanized antibodies in therapeutic applications. His extensive patent portfolio and collaborative efforts highlight his role as a leading inventor, paving the way for future developments in medical science and treatment options.